Rapid risk assessment: Human fatality from highly pathogenic avian influenza A(H5N1) virus infection in Guangdong province, China
Following reports of a human fatality due to highly pathogenic avian influenza A(H5N1) virus infection in China’s Guangdong province, the European Commission requested an update to the assessment of risk of human-to-human transmission occurring. ECDC does not consider that there is any change to the previous assessments that the risk for EU/EEA countries is very low.
Human infection with a novel avian influenza virus, A(H7N9), China - 2nd update, 8 May 2013
This second update to ECDC's initial risk assessment concludes that the risk of the disease spreading to Europe via humans or through poultry is still low at this time.
Diagnostic preparedness in Europe for detection of avian influenza A(H7N9) viruses
In China, a novel avian-origin reassortant influenza A(H7N9) virus has been detected in a number of human cases.
Rapid risk assessment on influenza A(H7N9) China, 12 April 2013
On 31 March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus isolated from three unlinked cases of severe respiratory disease in eastern China. This is the first time that human infection with avian influenza virus A(H7N9) has been identified.
Since then, human cases have continued to be reported from eastern China. As of 11 April, there were 38 laboratory-confirmed cases including ten deaths reported from four bordering provinces with a concentration of cases in and around Shanghai. Cases occur sporadically, without obvious epidemiological links. There is currently no confirmed human-to-human transmission.
Rapid risk assessment: Severe respiratory disease associated with a novel influenza A virus, A(H7N9) China
On 31 March 2013, the Chinese authorities announced the identification of a novel influenza A virus, A(H7N9), in three seriously ill people from two provinces presenting with respiratory infections. So far, no epidemiological link has been identified between those three patients. When testing for the influenza virus, the Chinese Center for Disease Control and Prevention identified genes from both A(H7N9) and A(H9N2) viruses, thus indicating a novel reassortant avian influenza A virus. In its initial assessment of the situation, the ECDC rapid risk assessment concludes that the risk of the spread of the virus in Europe can be considered low at this stage.
Communicable disease threats report, 10-16 November 2013, week 46
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 November 2013, and includes updates on avian influenza, cholera, dengue, influenza, MERS, polio and salmonellosis.
Rapid risk assessment: Human infection with a novel avian influenza A(H7N9) virus, China - Third update
This updated risk assessment summarises all available information on the novel avian influenza A(H7N9) and assesses the situation as of 27 January 2014, focusing on new developments since the ECDC rapid risk assessments of 3 April 2013, 12 April 2013 and 8 May 2013.
Communicable disease threats report 16-22 February 2014, week8
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 February 2014, and includes updates on avian influenza, chikungunya, dengue, seasonal influenza, measles, MERS, polio, rubella and Zika virus.
Rapid risk assessment: Human infections with avian influenza A viruses, China
This Rapid Risk Assessment summarises the latest information about human infections with avian influenza A viruses in China.
Communicable disease threats report, 5-11 October 2014, week 41
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 October 2014, and includes updates on influenza, West Nile virus, chikungunya, Marburg fever, Ebola virus, Enterovirus, avian influenza, MERS, dengue and polio.
- Avian influenza virus
- Chikungunya virus disease
- Democratic Republic of the Congo
- Ebola haemorrhagic fever
- Marburg haemorrhagic fever
- Middle East respiratory syndrome coronavirus
- Public health threat
- United States
- West Nile virus infection
- Western Africa